Are you a new member? Sign up now
Login area
| Sign up
close
APO-ROSUVASTATIN - 10mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 7496 | 186099/13 | APO-ROSUVASTATIN | 10mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 670,577 L.L | 23.08 | A1 | Apotex Inc | Canada | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C10AA07 | B | Rosuvastatin (calcium) - 10mg | 1711 | 195490/04 | CRESTOR | 10mg | 28 | Tablet, film coated | Oral | Omnipharma | IPR Pharmaceuticals | USA | 804,962 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 7861 | 186191/13 | CRESOTAB | 10mg | 30 | Tablet, film coated | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 517,379 L.L | 23.08 | A1 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 6342 | 168138/10 | CRESULIP 10 | 10mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 575,933 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 9609 | 87318/1 | LIPIROSE OBP 10 | 10mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 575,933 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 8873 | 186622/13 | PMS-ROSUVASTATIN | 10mg | 30 | Tablet | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 564,414 L.L | 23.08 | A1 | Pharmascience Inc | Canada | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 8118 | 36915/1 | PREVAST 10-IPS | 10mg | 30 | Tablet, film coated | Oral | IPS "Integrated Pharma Solutions SARL" | Benta SAL | Lebanon | 575,933 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 6302 | 167996/11 | ROSUCOR | 10mg | 30 | Tablet, film coated | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 487,623 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 11346 | FE15223/1 | ROSUPHAR | 10mg | 30 | Tablet, film coated | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 487,623 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 5484 | 195052/04 | ROSUVAS | 10mg | 30 | Tablet, film coated | Oral | Mediterranean Pharmaceutical Company | Sun Pharmaceuticals Industries Ltd | India | 450,187 L.L | 23.08 | A1 | Sun Pharmaceuticals Industries Ltd | India | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 8462 | 56614/1 | ROVASTIN | 10mg | 30 | Tablet | Oral | Pharmapro | Mediphar Laboratories | Lebanon | 618,168 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 7769 | 186812/14 | ROXARDIO | 10mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Pharmaline under license from Sandoz GmbH, Austria | Lebanon | 699,405 L.L | 23.08 | A1 | Lek Pharmaceuticals dd, Slovenia (raw material) | 2/5/2024 | 0 | |
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 3990 | 24356/06 | SINLIP | 10mg | 30 | Tablet, film coated | Oral | Droguerie Phenicia | Gador SA | Argentine | 563,070 L.L | 23.08 | A1 | Gador SA | Argentine | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 10mg | 7038 | 96883/12 | SUPERSTAT | 10mg | 30 | Tablet, coated | Oral | Abela Frères S.A.L. | Ibn Al Baytar | Tunisia | 517,379 L.L | 23.08 | A1 | Ibn Al Baytar | Tunisia | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024